China will honor its commitment to help and support other developing countries through making COVID-19 vaccines a public good that is accessible and affordable around the world, President Xi Jinping said on Nov 22.
China's National Health Commission said on Nov 23 that it received reports of 11 newly confirmed COVID-19 cases on the Chinese mainland on Nov 22, including two domestically transmitted cases and nine imported ones.
A Chinese inactivated COVID-19 vaccine candidate has been proved safe and tolerable and can induce a quick immune response, according to the findings from early and mid-stage clinical trials published in the journal The Lancet Infectious Diseases.
- NMPA Issues Announcement on Performing Consistency Evaluation of the Quality and Efficacy of Generic Chemical Injections
- NMPA Issues Guidance for On-Site Inspection of Independent Software Appended in Good Manufacturing Practice for Medical Devices
- NMPA Issues 5 Technical Review Guidances for the Registration of Tendon and Ligament Fixation Systems and Others